‘Survivorship’ is a rapidly growing field of research, as more cancer patients live longer, and require different types of support to get their lives back on track. Typically such research has been disconnected from clinical [more]
Anna Wagstaff looks at changes in the business, regulatory and science arenas that could open the way to delivering better cancer treatments, faster and cheaper. Of 91 new therapies approved for solid tumours between 2002 [more]
The topic of cancer survivorship is getting a lot of airing these days. There have been conferences dedicated to the topic – a sure indicator of interest. Professor Sir Mike Richards, England’s first National Cancer [more]
The EUROCARE 4 report has delivered an implicit merit mark to eastern European countries, whose relatively poor survival figures are now improving faster than those in the rest of Europe. But older patients are still [more]
Every year thousands of people die unnecessarily from cancer because their care is sub-optimal or arrives too late. Europe has known where the problems are for more than a decade and has the knowledge to [more]